A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome

Clinical trial NCT04608110 · RECRUITING

Trial details

NCT number: NCT04608110
Sponsor: Taiho Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)

Start date: 2020-10-30
Primary completion: 2027-12-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.